Black Diamond Therapeutics, Inc.·4

Jan 31, 4:36 PM ET

Yurasov Sergey 4

4 · Black Diamond Therapeutics, Inc. · Filed Jan 31, 2025

Insider Transaction Report

Form 4
Period: 2025-01-30
Yurasov Sergey
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Common Stock

    2025-01-30+75,00075,000 total
  • Award

    Stock Option (Right to Buy)

    2025-01-30+200,000200,000 total
    Exercise: $2.52Exp: 2035-01-29Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]Represents a grant of Restricted Stock Units ("RSUs") under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest as follows: 50% of the RSUs shall vest on January 30, 2026 and the remaining 50% of the RSUs shall vest on January 30, 2027, subject to the Reporting Person's continued service on each such vesting date.
  • [F2]25% of the shares subject to this option shall vest and become exercisable on January 30, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file
  • 4
    form4-01312025_090152.xmlPrimary